Drug prices based on success could speed up cancer patients' treatment
MedicalXpress - 02-21
Paying for cancer drugs based on how well they work in practice could help patients get new treatments faster, according to a Cancer Research UK report published today. As well as providing value for money for the NHS, companies whose medicines represent genuine advances would also be rewarded.This flexible way of paying for cancer medicines, known as outcome-based payment (OBP), would mean a drug's price could be adjusted based on how well it works for patients in the NHS. For example, the NHS could pay the company less for a drug that doesn't work as well as expected, but more if it does.